Patent · US Active

Process for producing oseltamivir phosphate and intermediate compound

US9139514B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2013
Grant dateSep 22, 2015
Priority date
Expiry dateMar 19, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Disclosed are a process suited to large scale synthesis with high yield for producing oseltamivir phosphate, in which a preparation of oseltamivir phosphate which is highly safe as a pharmaceutical product can be produced, and an intermediate compound for producing oseltamivir phosphate. In this production process, an intermediate compound represented by general formula (V) is synthesized by employing Michael reaction/Michael reaction/Horner-Wadsworth-Emmons reaction, and oseltamivir phosphate is produced by converting the substituent groups in this intermediate compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.